/LFST
LFST Stock - LifeStance Health Group, Inc.
Healthcare|Medical - Care FacilitiesNASDAQ
$7.05+1.59%
+$0.11 (+1.59%) • Dec 19
83
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.92
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.75
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+27.7%upside
Target: $9.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LFST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.98 – $7.12
TARGET (TP)$9.00
STOP LOSS$6.49
RISK/REWARD1:3.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.13
52W High$8.29
52W Low$3.74
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.25B | $1.06B | $859.54M | $667.51M | $377.22M |
| Gross Profit | $402.40M | $302.10M | $237.02M | $201.51M | $134.32M |
| Gross Margin | 32.2% | 28.6% | 27.6% | 30.2% | 35.6% |
| Operating Income | $-31,613,000 | $-189,134,000 | $-210,174,000 | $-286,353,000 | $15.44M |
| Net Income | $-57,443,000 | $-186,262,000 | $-215,564,000 | $-307,197,000 | $-38,070,000 |
| Net Margin | -4.6% | -17.6% | -25.1% | -46.0% | -10.1% |
| EPS | $-0.15 | $-0.51 | $-0.61 | $-1.05 | $-0.83 |
Company Overview
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
6
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
6 Bullish0 Neutral/Bearish
Price Targets
$8
Average Target
↑ 17.0% Upside
Now
$7
Low
$8
Average
$10
High
Based on 11 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 9th 2025 | Barclays | Initiation | Overweight | $8 |
| November 13th 2025 | BMO Capital Markets | Initiation | Outperform | $8 |
| July 25th 2025 | BTIG Research | Initiation | Buy | $8 |
| May 27th 2025 | UBS | Upgrade | Buy | $8.5 |
| April 8th 2025 | KeyBanc Capital Markets | Initiation | Overweight | $9 |
| April 3rd 2025 | Canaccord Genuity | Initiation | Buy | $8 |
| December 16th 2024 | Goldman | Upgrade | Buy | $10 |
| January 3rd 2024 | Barclays | Initiation | Underweight | $7 |
| May 15th 2023 | TD Cowen | Downgrade | Market Perform | $9← $8 |
| January 6th 2023 | Morgan Stanley | Upgrade | Overweight | $8 |
| November 7th 2022 | Jefferies | Resumed | Buy | $7.25 |
Earnings History & Surprises
LFSTBeat Rate
56%
Last 18 quarters
Avg Surprise
+0.8%
EPS vs Estimate
Beats / Misses
10/7
1 met exactly
Latest EPS
$0.00
Q4 2025
EPS Surprise History
Q1 24
-33.3%
$-0.12vs$-0.09
Q2 24
+33.3%
$-0.06vs$-0.09
Q3 24
+14.3%
$-0.06vs$-0.07
Q4 24
+71.4%
$-0.02vs$-0.07
Q1 25
+50.0%
$-0.02vs$-0.04
Q2 25
+104.6%
$0.00vs$-0.04
Q3 25
+66.7%
$-0.01vs$-0.03
Q4 25
+127.7%
$0.00vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.01 | $0.00 | +127.7% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $-0.03 | $-0.01 | +66.7% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $-0.04 | $0.00 | +104.6% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $-0.04 | $-0.02 | +50.0% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $-0.07 | $-0.02 | +71.4% | ✓ BEAT |
Q3 2024 | Aug 8, 2024 | $-0.07 | $-0.06 | +14.3% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $-0.09 | $-0.06 | +33.3% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $-0.09 | $-0.12 | -33.3% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $-0.07 | $-0.17 | -142.9% | ✗ MISS |
Q3 2023 | Aug 9, 2023 | $-0.09 | $-0.13 | -44.4% | ✗ MISS |
Q2 2023 | May 10, 2023 | $-0.11 | $-0.09 | +18.2% | ✓ BEAT |
Q1 2023 | Mar 8, 2023 | $-0.13 | $-0.13 | 0.0% | = MET |
Q4 2022 | Nov 8, 2022 | $-0.15 | $-0.11 | +26.7% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $-0.12 | $-0.19 | -58.3% | ✗ MISS |
Q2 2022 | May 9, 2022 | $-0.15 | $-0.18 | -20.0% | ✗ MISS |
Q1 2022 | Mar 10, 2022 | $-0.37 | $-0.32 | +13.5% | ✓ BEAT |
Q4 2021 | Nov 8, 2021 | $-0.27 | $-0.35 | -29.6% | ✗ MISS |
Q3 2021 | Aug 11, 2021 | $-0.06 | $-0.17 | -183.3% | ✗ MISS |
Q2 2021 | Jun 1, 2021 | — | $-0.02 | — | — |
Latest News
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $10
📈 PositiveBenzinga•Dec 12, 2025, 10:30 AM
Barclays Initiates Coverage On LifeStance Health Gr with Overweight Rating, Announces Price Target of $8
📈 PositiveBenzinga•Dec 9, 2025, 03:01 PM•Also:
BMO Capital Initiates Coverage On LifeStance Health Gr with Outperform Rating, Announces Price Target of $8
📈 PositiveBenzinga•Nov 13, 2025, 09:54 AM
UBS Maintains Buy on LifeStance Health Gr, Raises Price Target to $10
📈 PositiveBenzinga•Nov 7, 2025, 04:29 PM•Also:
LifeStance Health Group shares are trading higher after the company reported better-than-expected Q3 financial results.
📈 PositiveBenzinga•Nov 6, 2025, 02:01 PM
LifeStance Health Gr Sees Q4 Sales $368.000M-$388.000M vs $379.839M Est
📈 PositiveBenzinga•Nov 6, 2025, 11:05 AM
LifeStance Health Gr Lowers FY2025 Sales Guidance from $1.400B-$1.440B to $1.140B-$1.430B vs $1.414B Est
📉 NegativeBenzinga•Nov 6, 2025, 11:05 AM
LifeStance Health Gr Q3 EPS $0.00 Beats $(0.01) Estimate, Sales $363.809M Beat $355.604M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 11:03 AM
LifeStance Health spikes as UBS upgrades on valuation
📈 PositiveSeeking Alpha•May 27, 2025, 06:42 PM
Frequently Asked Questions about LFST
What is LFST's current stock price?
LifeStance Health Group, Inc. (LFST) is currently trading at $7.05 per share. The stock has moved +1.59% today.
What is the analyst price target for LFST?
The average analyst price target for LFST is $9.00, based on 1 analyst.
What sector is LifeStance Health Group, Inc. in?
LifeStance Health Group, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is LFST's market cap?
LifeStance Health Group, Inc. has a market capitalization of $2.74 billion, making it a mid-cap company.
Does LFST pay dividends?
No, LifeStance Health Group, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACHC
Acadia Healthcare Company, Inc.
$14.41
Mkt Cap: $1.3B
ADUS
Addus HomeCare Corporation
$112.82
Mkt Cap: $2.1B
ARDT
Ardent Health Partners, LLC
$8.81
Mkt Cap: $1.3B
ASTH
Astrana Health, Inc.
$23.87
Mkt Cap: $1.2B
AVAH
Aveanna Healthcare Holdings Inc.
$9.09
Mkt Cap: $1.9B
BKD
Brookdale Senior Living Inc.
$10.79
Mkt Cap: $2.6B
CLOV
Clover Health Investments, Corp.
$2.58
Mkt Cap: $1.3B
MD
Pediatrix Medical Group, Inc.
$21.91
Mkt Cap: $1.9B
NHC
National HealthCare Corporation
$141.64
Mkt Cap: $2.2B
SEM
Select Medical Holdings Corporation
$15.01
Mkt Cap: $1.9B
Explore stocks similar to LFST for comparison